Strata Decision Technology Names Michelson CEO

Strata Decision Technology, a developer of financial and business analytics software for the healthcare market, has added Dan Michelson as chief executive officer. Michelson most recently served as Chief Marketing and Strategy Officer for Allscripts Healthcare Solutions, a publicly traded company.



Strata Decision Technology (Strata Decision), a pioneer and leader in the development of innovative software tools for financial and business analytics in the U.S. healthcare market, today announced the appointment of Dan Michelson as Chief Executive Officer. With over 20 years of experience, including over a decade as a leader in the healthcare information technology market, Michelson is a well-respected healthcare industry veteran with a strong track record of driving growth in healthcare businesses.


Michelson most recently served as Chief Marketing and Strategy Officer for Allscripts Healthcare Solutions (NASDAQ: MDRX). In his 12 years with the Company, he was one of the key leaders in growing the organization from 100 to over 6,000 employees and from $26 million to over $1.4 billion in annual revenue, one of the great growth stories in healthcare information technology over the last decade. During his time at Allscripts, he led teams in product management, strategic planning, marketing and sales.


Strata Decision’s SaaS (Software as a Service) solutions are used by over 1,000 healthcare organizations, including major academic medical centers, community hospitals, children’s hospitals and many of the largest and most influential healthcare systems in the U.S. including Adventist Health, Bon Secours Health System, Christus Health System, Cleveland Clinic, Dignity Health (formerly Catholic Healthcare West), Duke University Health System, Intermountain Healthcare, Legacy Health System, NYU Medical Center, Spectrum Health and Yale New Haven Health.


“Strata Decision is exceptionally well positioned with unparalleled analytics capabilities, real insights that improve financial performance, and, ultimately, result in more and better healthcare,” stated Michelson. “With a solid foundation, including an innovative set of solutions and strong client base of top-tier organizations, I couldn’t be more excited to join the team and help drive the next stage of growth for the company.”


Michelson’s prior experience includes providing strategy and operations redesign consulting for many leading hospitals and health systems in the U.S. as well as serving in a number of roles at both Baxter International (NYSE: BAX), a leading medical supply company, and AstraZeneca (NYSE: AZN), one the world’s largest pharmaceutical companies.


“Dan brings significant leadership experience guiding high-growth companies at the intersection of healthcare, and information technology. He has worked across multiple market segments including hospitals, health systems, and physician practices and across many management disciplines, with a particular strength in product strategy, marketing, sales, and general management,” stated David Bainbridge, a member of Strata Decision’s Board of Directors and a Managing Director for Veronis Suhler Stevenson (VSS), a leading global private investment firm. “He is a strong addition to a very solid management team.”


Dr. Catherine Kleinmuntz and Dr. Don Kleinmuntz, the co-founders of Strata Decision, will continue to serve on the Company’s executive team in significant senior leadership roles. Dr. Catherine Kleinmuntz, a respected industry leader in healthcare financial management and strategic planning, will serve as Executive Vice President and Chief Client Officer. Dr. Don Kleinmuntz, an established expert in business analytics, decision-making tools and processes, and information technology, will serve as Executive Vice President and Chief Analytics Officer, overseeing product direction for the Company. He will also serve on Strata Decision’s Board of Directors, along with Mr. Michelson.


“This is a very strong company with extremely attractive growth prospects   in a dynamic market,” stated Dr. Don Kleinmuntz. “Both Catherine and I are very proud of where the company is today and look forward to partnering with Dan to take the company to the next level.”